Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: J ECT. 2017 Dec;33(4):268–271. doi: 10.1097/YCT.0000000000000413

Table 2.

Outcome Measures (mean±sd)

Outcome HAM-D BDI MMSE
Group Ketamine Methohexital Ketamine Methohexital Ketamine Methohexital
Baseline 27.4±5.0 25.8±2.7 34.0±4.5 36.0±10.0 27.5±2.1 26.0±2.1
Post ECT #1 21.4±4.6 24.3±5.2 24.3±10.3 18.8±10.3 27.8±2.1 26.6 ±3.3
Post ECT #2 18.8±4.2 18.4±7.3 16.4±7.2 19.3±14.4 26.8±2.3 26.1±2.7
Post ECT #3 13.3±4.4 14.1±4.4 13.5±5.9 11.3±5.9 27.3±2.3 26.6±3.3
Post ECT #4 13.9±4.3 16.8±7.7 18.6±6.2 15.0±8.1 27.2±2.6 26.3±2.5
Post ECT #5 12.8±4.6 14.3±5.1 15.3±2.6 16.3±11.7 25.0 ±0.0 26.7 ±3.1
HHS Vulnerability Disclosure